Literature DB >> 91607

Iron-bleomycin interactions with oxygen and oxygen analogues. Effects on spectra and drug activity.

R M Burger, J Peisach, W E Blumberg, S B Horwitz.   

Abstract

Despite extensive structural dissimilarities, iron . bleomycin complexes and heme-containing oxygenases display remarkable similarities in binding oxygen antagonists and in spectral properties deriving from bound iron. Fe(II)-bleomycin reversibly forms a complex with either CO or isocyanide (lambda max = 384 and 497 nm, respectively), either of which interfere with its oxygen-dependent cleavage of DNA. A similar but paramagnetic complex forms with NO (lambda max = 470 nm; AN = 24 G). In contrast, cyanide enhances bleomycin activity against DNA. Complexes of bleomycin and FE(III), formed either by direct association or by autoxidation of the Fe(II) . bleomycin complex, exhibit indistinguishable EPR and visible spectra, which change characteristically with pH. At neutral pH, Fe(III) . bleomycin is a low spin complex (g = 2.45, 2.18, 1.89; lambda max = 365, 384 nm) and, at low pH, it is a high spin rhombic complex (geff = 9.4, 4.3; lambda max = 430 nm). These complexes are interconvertible (pK 4.3). Fe(II) . bleomycin oxidation, although reversible by spectral criteria, is accompanied by drug inactivation unless DNA is present.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 91607

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Thiol-redox antioxidants protect against lung vascular endothelial cytoskeletal alterations caused by pulmonary fibrosis inducer, bleomycin: comparison between classical thiol-protectant, N-acetyl-L-cysteine, and novel thiol antioxidant, N,N'-bis-2-mercaptoethyl isophthalamide.

Authors:  Rishi B Patel; Sainath R Kotha; Lynn A Sauers; Smitha Malireddy; Travis O Gurney; Niladri N Gupta; Terry S Elton; Ulysses J Magalang; Clay B Marsh; Boyd E Haley; Narasimham L Parinandi
Journal:  Toxicol Mech Methods       Date:  2012-06       Impact factor: 2.987

2.  Mechanism of DNA cleavage by cationic manganese porphyrins: hydroxylations at the 1'-carbon and 5'-carbon atoms of deoxyriboses as initial damages.

Authors:  G Pratviel; M Pitié; J Bernadou; B Meunier
Journal:  Nucleic Acids Res       Date:  1991-11-25       Impact factor: 16.971

3.  The role of the gulose-mannose part of bleomycin in activation of iron-molecular oxygen complexes.

Authors:  A Kénani; C Bailly; N Helbecque; J P Catteau; R Houssin; J L Bernier; J P Hénichart
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

Review 4.  Mechanisms of bleomycin-induced lung damage.

Authors:  J Hay; S Shahzeidi; G Laurent
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

5.  Characterization of a transport and detoxification pathway for the antitumour drug bleomycin in Saccharomyces cerevisiae.

Authors:  Mustapha Aouida; Anick Leduc; Huijie Wang; Dindial Ramotar
Journal:  Biochem J       Date:  2004-11-15       Impact factor: 3.857

6.  Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and Th1/Th2 balance.

Authors:  Norihiro Kikuchi; Yukio Ishii; Yuko Morishima; Yuichi Yageta; Norihiro Haraguchi; Ken Itoh; Masayuki Yamamoto; Nobuyuki Hizawa
Journal:  Respir Res       Date:  2010-03-18

Review 7.  Protective mechanisms against the antitumor agent bleomycin: lessons from Saccharomyces cerevisiae.

Authors:  Dindial Ramotar; Huijie Wang
Journal:  Curr Genet       Date:  2003-04-16       Impact factor: 3.886

8.  Interactions among iron(II) bleomycin, Lewis bases, and DNA.

Authors:  W E Antholine; D H Petering; L A Saryan; C E Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

9.  Superoxide protects Escherichia coli from bleomycin mediated lethality.

Authors:  Richard M Burger; Karl Drlica
Journal:  J Inorg Biochem       Date:  2009-07-17       Impact factor: 4.155

10.  Potentiation of bleomycin cytotoxicity in Saccharomyces cerevisiae.

Authors:  C W Moore
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.